Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intuniv for hyperactivity in PDD
NCT01238575Phase 4Completed
- Sponsor
- Yale University
- Start
- Dec 2011
- Primary completion
- Mar 2014
- Countries
- 1
01
Overview
A Phase 4 trial of guanfacine in attention deficit hyperactivity disorder (ADHD), sponsored by Yale University. Started Dec 2011; status: completed.
02
Drugs
guanfacine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01238575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01238575.